A multi-center, phase II study of Olaparib maintenance therapy in patients with high-grade ovarian cancer, combined with translational research by integrated genome-wide analysis
Latest Information Update: 20 Dec 2021
At a glance
- Drugs Olaparib (Primary)
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 20 Dec 2021 New trial record